Name: Mainz Biomed N.V. (MYNZ) Financial Statements
Creator: FinSpry

Mainz Biomed Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Mainz Biomed N.V. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.89	0.90	0.53	0.58	0.49
Cost of Revenue	0.32	0.39	0.35	0.40	0.37
Gross Profit	0.57	0.51	0.18	0.18	0.12
Operating Expenses
Research & Development	5.84	9.59	5.02	0.48	0.31
Selling, General & Administrative	12.77	17.56	21.45	9.38	0.48
Operating Expenses	18.99	27.15	26.63	9.90	0.80
Operating Income	-18.42	-26.64	-26.44	-9.72	-0.67
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	1.08	-0.56	0.29	0.34	-0.27
Other Income/Expense	-2.16	0.20	0.35	-1.63	0.33
Income
Income Before Tax	-21.65	-26.30	-26.39	-11.69	-0.59
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-21.65	-26.30	-26.39	-11.69	-0.59
Net Income - Continuous Operations	-21.65	-26.30	-26.39	-11.69	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-19.56	-26.07	-25.72	-11.28	-0.61
EBIT	-20.58	-26.64	-26.10	-11.35	-0.67
Depreciation & Amortization	0.38	0.57	0.16	0.04	0.06
Earnings Per Share
Basic EPS	-22.00	-65.00	-75.00	-65.00	-4.00
Diluted EPS	-22.00	-65.00	-75.00	-65.00	-4.00
Basic Shares Outstanding	0.97	0.41	0.35	0.18	0.14
Diluted Shares Outstanding	0.97	0.41	0.35	0.18	0.14